Braidwell-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "KNSA",
  "NUVL",
  "ASND",
  "EWTX",
  "TRVI",
  "RGEN",
  "KRYS",
  "ARGX",
  "INSP",
  "MDGL",
  "APLS",
  "SKYE",
  "ADPT",
  "BCAX",
  null,
  "REPL",
  "LEGN",
  null,
  null,
  null,
  null,
  "SYRE",
  "APGE",
  "ISRG",
  "GH",
  null,
  null,
  "NBIX",
  null,
  "LUNG",
  null,
  null,
  null,
  null,
  null,
  "ZURA",
  "TMDX",
  "TMO",
  "ATEC",
  null,
  "DYN",
  null,
  "MRVI",
  null,
  "GKOS",
  "SRPT",
  "PEN",
  "ALGN",
  "HROW",
  "IRWD",
  "VKTX",
  "XENE",
  "KIDS",
  "XNCR",
  "ORKA",
  "IRTC",
  "BPMC",
  "CELC",
  "CSTL",
  "CGON",
  "CGEM",
  "DHR",
  "DAWN",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 64
Total Value: 2844802567
Accession Number: 0001420506-25-001293
Form Type: 13F-HR
CIK: braidwell-lp
Manager Name: Braidwell-Lp

Data Enrichment

75% identified

48 identified16 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

64 positions • $2.8B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 4

Sort by:

Zura Bio Ltd

ZURA|G9TY5A101

Shares:2.5M

Value:$3.2M

% of Portfolio:0.1% ($3.2M/$2.8B)

08659B102

Shares:140.0K

Value:$1.7M

% of Portfolio:0.1% ($1.7M/$2.8B)

Skye Bioscience, Inc.

SKYE|83086J200

Shares:825.7K

Value:$1.3M

% of Portfolio:0.0% ($1.3M/$2.8B)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:72.1K

Value:$453.4K

% of Portfolio:0.0% ($453.4K/$2.8B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Zura Bio Ltd(ZURAcusipG9TY5A101)	2.5M	QoQ 0.00% (-0) YoY NEW(+2.5M)	All Managers (Combined)	$3.2M	0.1% ($3.2M/$2.8B)	QoQ -48.39% (-$3.0M) YoY NEW(+$3.2M)
(cusip08659B102)✕	140.0K	QoQ NEW(+140.0K) YoY NEW(+140.0K)	All Managers (Combined)	$1.7M	0.1% ($1.7M/$2.8B)	QoQ NEW(+$1.7M) YoY NEW(+$1.7M)
Skye Bioscience, Inc.(SKYEcusip83086J200)	825.7K	QoQ 0.00% (-0) YoY NEW(+825.7K)	All Managers (Combined)	$1.3M	0.0% ($1.3M/$2.8B)	QoQ -43.81% (-$1.0M) YoY NEW(+$1.3M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	72.1K	QoQ NEW(+72.1K) YoY NEW(+72.1K)	All Managers (Combined)	$453.4K	0.0% ($453.4K/$2.8B)	QoQ NEW(+$453.4K) YoY NEW(+$453.4K)